06.11.2024 13:08:50
|
Charles River Laboratories International Inc. Q3 Profit Decreases, But Beats Estimates
(RTTNews) - Charles River Laboratories International Inc. (CRL) announced earnings for third quarter that decreased from the same period last year but beat the Street estimates.
The company's bottom line came in at $68.68 million, or $1.33 per share. This compares with $87.39 million, or $1.69 per share, in last year's third quarter.
Excluding items, Charles River Laboratories International Inc. reported adjusted earnings of $133.75 million or $2.59 per share for the period.
Analysts on average had expected the company to earn $2.43 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 1.7% to $1.009 billion from $1.026 billion last year.
Charles River Laboratories International Inc. earnings at a glance (GAAP) :
-Earnings (Q3): $68.68 Mln. vs. $87.39 Mln. last year. -EPS (Q3): $1.33 vs. $1.69 last year. -Revenue (Q3): $1.009 Bln vs. $1.026 Bln last year.
-Guidance: Full year EPS guidance: $10.10 - $10.30
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Charles River Laboratories International Inc.mehr Nachrichten
16.01.25 |
Angespannte Stimmung in New York: S&P 500 verbucht nachmittags Verluste (finanzen.at) | |
16.01.25 |
NYSE-Handel: S&P 500 mittags mit Gewinnen (finanzen.at) | |
16.01.25 |
Minuszeichen in New York: S&P 500 zum Start des Donnerstagshandels im Minus (finanzen.at) | |
15.01.25 |
Börse New York: S&P 500 beendet den Mittwochshandel im Plus (finanzen.at) | |
14.01.25 |
NYSE-Handel: S&P 500 notiert zum Handelsende im Plus (finanzen.at) | |
14.01.25 |
Dienstagshandel in New York: S&P 500 am Dienstagnachmittag in der Gewinnzone (finanzen.at) | |
14.01.25 |
S&P 500-Handel aktuell: S&P 500 im Minus (finanzen.at) | |
14.01.25 |
S&P 500 aktuell: S&P 500 beginnt Dienstagssitzung in der Gewinnzone (finanzen.at) |
Analysen zu Charles River Laboratories International Inc.mehr Analysen
Aktien in diesem Artikel
Charles River Laboratories International Inc. | 160,15 | -4,93% |